ZCA
ELV icon

Zeke Capital Advisors’s Elevance Health ELV Stock Holding History

Zeke Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.52M Sell
2,956
-992
-25% -$504K 0.1% 98
2022
Q3 		$1.79M Hold
3,948
– – 0.13% 77
2022
Q2 		$1.91M Sell
3,948
-1,403
-26% -$694K 0.13% 79
2022
Q1 		$2.63M Buy
5,351
+1,816
+51% +$830K 0.13% 74
2021
Q4 		$1.64M Sell
3,535
-333
-9% -$140K 0.1% 68
2021
Q3 		$1.44M Sell
3,868
-174
-4% -$66.1K 0.08% 78
2021
Q2 		$1.54M Buy
4,042
+4
+0.1% +$1.53K 0.1% 83
2021
Q1 		$1.45M Buy
4,038
+556
+16% +$179K 0.1% 71
2020
Q4 		$1.12M Sell
3,482
-346
-9% -$106K 0.09% 74
2020
Q3 		$1.03M Buy
3,828
+1,492
+64% +$401K 0.12% 57
2020
Q2 		$614K Sell
2,336
-1,931
-45% -$515K 0.12% 83
2020
Q1 		$969K Sell
4,267
-12,505
-75% -$3.41M 0.27% 51
2019
Q4 		$5.07M Sell
16,772
-963
-5% -$265K 0.42% 44
2019
Q3 		$4.26M Buy
17,735
+833
+5% +$228K 0.38% 54
2019
Q2 		$4.77M Buy
16,902
+4,912
+41% +$1.34M 0.45% 49
2019
Q1 		$3.44M Buy
11,990
+1,600
+15% +$463K 0.32% 69
2018
Q4 		$2.73M Buy
10,390
+3,940
+61% +$1.08M 0.26% 78
2018
Q3 		$1.77M Hold
6,450
– – 0.14% 119
2018
Q2 		$1.53M Hold
6,450
– – 0.14% 120
2018
Q1 		$1.42M Hold
6,450
– – 0.13% 134
2017
Q4 		$1.45M Buy
6,450
+2,048
+47% +$436K 0.15% 123
2017
Q3 		$836K Buy
4,402
+2,457
+126% +$468K 0.11% 143
2017
Q2 		$366K Buy
1,945
+218
+13% +$39.2K 0.07% 166
2017
Q1 		$286K Buy
1,727
+240
+16% +$38.2K 0.06% 185
2016
Q4 		$214K Buy
+1,487
New +$199K 0.06% 178

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Zeke Capital Advisors's ELV Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Elevance Health (ELV) stake by 25% in Q4 2022, selling an estimated $504K and leaving 2,956 shares worth $1.52M. The position accounts for 0.1% of the portfolio, ranked #98.

Zeke Capital Advisors first reported a position in ELV in Q4 2016 and has held it in 25 quarters since. The position peaked at $5.07M in Q4 2019. 1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Zeke Capital Advisors held 2,956 shares of Elevance Health worth $1.52M as of Q4 2022.
  • Zeke Capital Advisors sold 992 Elevance Health shares in Q4 2022, an estimated $504K.
  • Elevance Health made up 0.1% of Zeke Capital Advisors's portfolio in Q4 2022, its #98 holding.
  • Zeke Capital Advisors first reported a position in Elevance Health in Q4 2016 and has held it in 25 quarters since.
  • Zeke Capital Advisors's Elevance Health position peaked at $5.07M in Q4 2019.
  • 1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.